PET/CT early restaging best suited for prostate cancer with fast-rising PSA

December 20, 2012

After prostatectomy, prostate cancer patients with a short prostate-specific antigen (PSA) doubling time should undergo [11C]choline PET/CT for early restaging to optimize potentially needed salvage therapy, according to a study published in the January issue of Journal of Urology .